Drug Pipeline
Beyond Opioids: Five Experimental Painkillers Researchers Are Watching Closely
From sodium channel blockers to next-generation NGF antibodies, a wave of non-opioid analgesics is moving through late-stage clinical trials. Here's a look at five candidates that could shape the future of pain care in the United States.